19-35526855-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001166034.2(SBSN):c.1427C>T(p.Ala476Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,612,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A476E) has been classified as Uncertain significance.
Frequency
Consequence
NM_001166034.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SBSN | NM_001166034.2 | c.1427C>T | p.Ala476Val | missense_variant | 1/4 | ENST00000452271.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SBSN | ENST00000452271.7 | c.1427C>T | p.Ala476Val | missense_variant | 1/4 | 1 | NM_001166034.2 | P2 | |
SBSN | ENST00000518157.1 | c.398C>T | p.Ala133Val | missense_variant | 2/5 | 1 | A2 | ||
SBSN | ENST00000588674.5 | c.315+1052C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000179 AC: 27AN: 151064Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000271 AC: 68AN: 251048Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135720
GnomAD4 exome AF: 0.000125 AC: 183AN: 1461820Hom.: 0 Cov.: 42 AF XY: 0.000142 AC XY: 103AN XY: 727212
GnomAD4 genome AF: 0.000179 AC: 27AN: 151064Hom.: 0 Cov.: 31 AF XY: 0.000203 AC XY: 15AN XY: 73718
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at